Julio Ochoa

Dr. Julio Ochoa

Institute of Nutrition and Food Technology, Universidad de Granada, "José Mataix Verdú", Granada, Spain
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2004 in Carcinogenesis
Verified
Journal Article
Closed access
PDF file
Julio OchoaJulio Ochoa
Julio Ochoa
AFAndrew J Farquharson
Andrew J Farquharson
IGIan Grant
Ian Grant
LML E Moffat
L E Moffat
SHSteven D Heys
Steven D Heys
KWKlaus W J Wahle
Klaus W J Wahle
The aims of this study were to examine the anti-proliferative effects of different concentrations of a commercial preparation of conjugated linoleic acids (CLA) mixture of isomers [cis-9, trans-11 CLA (c9,t11 CLA): trans-10, cis-12 CLA (50:50)] and their constituent isomers on PC-3, a human prostatic carcinoma cell line, and to study their effects on gene expression (mRNA and protein levels) of different enzymes and oncoproteins involved in oncogenesis and progression of prostate cancer. This includes pathways for arachidonic acid metabolism [cyclooxygenase 1 (COX-1), 2 (COX-2) and 5-lipoxygenase (5-LOX)], apoptosis (bcl-2) and cell cycle control (p21WAF/Cip1). Our results indicate a significant decrease in PC-3 proliferation elicited by CLA, although with high variability between isomers. The trans-10, cis-12 CLA was the most effective isomer (55% inhibition). This isomer was also able to decrease bcl-2 gene expression and to increase p21WAF1/Cip1 mRNA levels (60% increase at highest concentration). In contrast, cis-9, trans-11 had no effect on these proteins but had a clear effect on 5-LOX expression and to a lesser degree on COX-2 protein level isomers. In conclusion, the anti-proliferative effects on PC-3 of CLA mixture and their constituent isomers are not equivalent, due to the different pathways involved for individual isomers. Trans-10, cis-12 seems to work preferentially through modulation of apoptosis and cell cycle control, while c9,t11 CLA isomer affects arachidonic acid metabolism.

20 December 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
Jorge Moreno-FernandezJorge Moreno-Fernandez
Jorge Moreno-Fernandez
Julio OchoaJulio Ochoa
Julio Ochoa
JCJavier Diaz Castro
Javier Diaz Castro
Javier Díaz CastroJavier Díaz Castro
Javier Díaz Castro
Early programming is the adaptation process by which nutrition and environmental factors alter development pathways during prenatal growth, inducing changes in postnatal metabolism and diseases. The aim of this narrative review, is evaluating the current knowledge in the scientific literature on the effects of nutrition, environmental factors, physical activity and sleep on development pathways. If in utero adaptations were incorrect, this would cause a mismatch between prenatal programming and adulthood. Adequate caloric intake, protein, mineral, vitamin, and long-chain fatty acids, have been noted for their relevance in the offspring brain functions and behavior. Fetus undernutrition/malnutrition causes a delay in growth and have detrimental effects on the development and subsequent functioning of the organs. Pregnancy is a particularly vulnerable period for the development of food preferences and for modifications in the emotional response. Maternal obesity increases the risk of developing perinatal complications and delivery by cesarean section and has long-term implications in the development of metabolic diseases. Physical exercise during pregnancy contributes to overall improved health post-partum. It is also interesting to highlight the relevance of sleep problems during pregnancy, which influence adequate growth and fetal development. Taking into account these considerations, we conclude that nutrition and metabolic factors during early life play a key role of health promotion and public health nutrition programs worldwide to improve the health of the offspring and the health costs of hospitalization.

21 April 2011 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
Julio OchoaJulio Ochoa
Julio Ochoa
Javier Díaz CastroJavier Díaz Castro
Javier Díaz Castro
NKNaroa Kajarabille
Naroa Kajarabille
CGCarmen García
Carmen García
IGIsabel María Guisado-Requena
Isabel María Guisado-Requena
RGRafael Guisado
Rafael Guisado

3 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMaria Puche-Juarez
Maria Puche-Juarez
JTJuan M. Toledano
Juan M. Toledano
Jorge Moreno-FernandezJorge Moreno-Fernandez
Jorge Moreno-Fernandez
YOYolanda Gálvez Ontiveros
Yolanda Gálvez Ontiveros
Ana RivasAna Rivas
Ana Rivas
Julio OchoaJulio Ochoa
Julio Ochoa
Endocrine disrupting chemicals (EDCs) are exogenous substances widely disseminated both in the environment and in daily-life products which can interfere with the regulation and function of the endocrine system. These substances have gradually entered the food chain, being frequently found in human blood and urine samples. This becomes a particularly serious issue when they reach vulnerable populations such as pregnant women, whose hormones are more unstable and vulnerable to EDCs. The proper formation and activity of the placenta, and therefore embryonic development, may get seriously affected by the presence of these chemicals, augmenting the risk of several pregnancy complications, including intrauterine growth restriction, preterm birth, preeclampsia, and gestational diabetes mellitus, among others. Additionally, some of them also exert a detrimental impact on fertility, thus hindering the reproductive process from the beginning. In several cases, EDCs even induce cross-generational effects, inherited by future generations through epigenetic mechanisms. These are the reasons why a proper understanding of the reproductive and gestational alterations derived from these substances is needed, along with efforts to establish regulations and preventive measures in order to avoid exposition (especially during this particular stage of life).

1 May 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
Julio OchoaJulio Ochoa
Julio Ochoa
RPReinald Pamplona
Reinald Pamplona
MRM. Carmen Ramirez-Tortosa
M. Carmen Ramirez-Tortosa
Sergio Granados-PrincipalSergio Granados-Principal
Sergio Granados-Principal
PPPatricia Perez-Lopez
Patricia Perez-Lopez
José L. QuilesJosé L. Quiles
José L. Quiles

16 May 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Jorge Moreno-FernandezJorge Moreno-Fernandez
Jorge Moreno-Fernandez
Julio OchoaJulio Ochoa
Julio Ochoa
Yemisi Latunde-DadaYemisi Latunde-Dada
Yemisi Latunde-Dada
Javier Díaz CastroJavier Díaz Castro
Javier Díaz Castro
Iron is an essential micronutrient that is involved in many functions in humans, as it plays a critical role in the growth and development of the central nervous system, among others. Premature and low birth weight infants have higher iron requirements due to increased postnatal growth compared to that of term infants and are, therefore, susceptible to a higher risk of developing iron deficiency or iron deficiency anemia. Notwithstanding, excess iron could affect organ development during the postnatal period, particularly in premature infants that have an immature and undeveloped antioxidant system. It is important, therefore, to perform a review and analyze the effects of iron status on the growth of premature infants. This is a transversal descriptive study of retrieved reports in the scientific literature by a systematic technique. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were adapted for the review strategy. The inclusion criteria for the studies were made using the PICO (population, intervention, comparison, outcome) model. Consequently, the systematic reviews that included studies published between 2008–2018 were evaluated based on the impact of iron status on parameters of growth and development in preterm infants.